Cerepak Brad M

Dover CFO Brad Cerepak sold 14,818 shares at $175.00 on 2024-09-06, reducing holdings by -54.6% to 12,324 shares.

Brad Cerepak, Senior VP & CFO of Dover, executed a substantial sale of 14,818 shares at $175.00, representing -54.6% of his pre-transaction holdings. The sale moved DOV stock within 5.2% of its 52-week high ($191.49), and current price of $181.45 stands 3.6% above the transaction price. Examining his prior trades at Dover specifically, Cerepak's five previous sales show mixed outcomes: two with positive 90-day returns (+13.0%, +18.2%) and two with near-zero or negative 90-day returns, with a 0 out of 4 well-timed rate at the 90-day mark. His cross-ticker track record shows 6 prior sells averaging 7.9% 90-day gains and a 0.00% well-timed rate, indicating his sales have historically been followed by stock appreciation rather than declines. The company trades at a P/E of 16.63 with annual revenue growth of -0.8%, and this represents a material reduction in the insider's equity stake in the business.

DOV CFO Brad M Cerepak sold 4,341 shares at $184.59 on 2024-07-31; stock now $179.15.

Brad M Cerepak, Senior VP & CFO of Dover Corp, sold 4,341 shares at $184.59 on 2024-07-31, reducing his holdings by -26.0% to 12,324 shares post-transaction. The sale occurred near the stock's 52-week high of $191.49, with the shares now trading at $179.15 (-6.4% from peak). His prior five sales at Dover have shown a 0% well-timed rate at the 90-day mark, with an average 90-day return of +7.9%, indicating that his prior sells preceded stock gains rather than declines. The company's fundamentals show modest deterioration with annual revenue growth of -0.8%, though current valuation at 16.42 P/E remains reasonable relative to recent range trading. This sale represents a material reduction in insider stake but follows a consistent selling pattern over the past 18 months without predictive timing value.